- Johnson & Johnson (NYSE:JNJ) has filed the latest lawsuit to combat illicit sales of drugs in the U.S., alleging that several drug distributors and pharmacies are selling counterfeit versions of its HIV drugs.
- J&J said in a suit that in some cases, bottles labeled as one drug were filled with pills of a different HIV medicine, writes Wall Street Journal.
- In at least one instance, a bottle purporting to be HIV medication contained antipsychotic pills, J&J said in court documents.
- Related: Gilead Alleges Counterfeiting Network Sold Fake HIV Drugs.
- J&J alleged in its suit that three drug distributors - SafeChain Solutions LLC, ProPharma Distribution LLC, and Scripts Wholesale Inc - have sold large quantities of counterfeit HIV medications.
- J&J alleged that several complaints of pills in the wrong bottle could be traced to SafeChain and Scripts and that ProPharma acknowledged possessing hundreds of bottles of J&J HIV medication that proved to be counterfeit.
- Price Action: JNJ shares closed at $184.73 on Tuesday.
- Image by Tumisu from Pixaby
